Colombian pneumonia study reveals key infection patterns
NCT ID NCT07354425
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at 688 adults hospitalized with pneumonia in 11 hospitals in Colombia to find out how many cases were caused by pneumococcal bacteria. Researchers also identified which bacterial strains were most common and whether current vaccines cover them. The goal is to help improve vaccination strategies in the region.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could help public health officials choose the best pneumococcal vaccine for adults in Colombia.
- What could go wrong
- This is an observational study, not a treatment trial. It describes what is happening but does not test a new drug or vaccine.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
688 people
The number who actually took part.
- Started
-
Jun 2022
- Finished
-
Feb 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population will consist of adults aged 18 years or older hospitalized with community-acquired pneumonia (CAP) in the Sabana Centro region of Colombia. This region includes 11 municipalities around Bogotá and represents a diverse socio-economic and demographic population with a well-organized healthcare system.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * (1) Age ≥ 18 years old. * (2) Hospitalized at one of the hospitals of Sabana Centro Region, including both in-patient and observation status stay. * (3) Clinical signs and/or symptoms of an acute respiratory illness, as defined by ≥ 1 of the * following: * -New or worsening shortness of breath in the past 7 days * -New or worsening cough in the past 7 days * -New or worsening sputum production in the past 7 days * -New or worsening chest pain in the past 7 days * -Tachypnea to respiratory rate ≥ 22 breaths/min, not known to be chronic * -Hypoxia to SpO2 ≤ 92% not known to be chronic * -Initiation of invasive or non-invasive mechanical ventilation * (4) Clinical signs and/or symptoms of an acute infection, as defined by ≥ 1 of the following: * -Body temperature ≥ 38º C (100.4º F) or ≤ 35.5º C (95.9º F) * -Reported fever, chills, or feeling feverish at home without explicit documentation of a fever within the past 7 days * -White blood cell count \> 10.7 or \< 3.9 thousand cells/mcL-C-reactive protein \> 10 mg/L * -Altered mental status * (5) Radiologic evidence of pneumonia interpreted by a radiologist, defined as ≥ 1 of the following findings on chest x-ray (CXR), computed tomography (CT), or lung ultrasound completed within 48 hours before or after hospital admission: * -Pulmonary infiltrate not known to be chronic * -Pulmonary opacity is not known to be chronic (including ground-glass opacities on CT) * -Pulmonary consolidation is not known to be Exclusion Criteria: * (1) Enrollment in this study within the past 90 days. * (2) Development of pneumonia (as defined in the inclusion criteria) more than 48 hours after hospital admission (pneumonia developed 48 hours after admission will be considered hospital-acquired pneumonia). * (3) Inability to obtain consent from patient or surrogate for this study within 48 hours of hospital admission (including time at a transferring hospital before admission at a study hospital). * (4) Inability or unwillingness of the patient to provide any of the samples (Blood, Urine, and Sputum) within 48 hours of hospital admission (including time at a transferring hospital before admission at a study hospital). * (5) Non-pneumonia illness completely explains the patient's acute symptoms. Alternative non-pneumonia illnesses could include pulmonary embolism, acute heart failure, lung cancer, and pulmonary hemorrhage.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Community acquired pneumonia (CAP) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centro Medico San Luis Clinica Quirurgica SAS
Cajicá, Colombia
-
Clinica Universidad de La Sabana
Chía, Cundinamarca, 250002, Colombia
-
Clinica de Marly Jorge Cavelier Gaviria SAS
Chía, Cundinamarca, 250002, Colombia
-
ESE Hospital Nuestra Señora del Carmen de Tabio
Tabio, Colombia
-
ESE Hospital San Antonio de Chia
Chía, Cundinamarca, 250002, Colombia
-
ESE Hospital San Vicente de Paul Nemocon
Nemocón, Colombia
-
ESE Hospital Santa Rosa de Tenjo
Tenjo, Colombia
-
ESE Hospital divino Salvador Sopo
Sopó, Colombia
-
Hospital Nuestra Señora del Transito de Tocancipa
Tocancipá, Colombia
-
Hospital Universitario de la Samaritana Regional
Zipaquirá, Colombia
-
Hospital Universitario de la Samaritana sede Funcional
Zipaquirá, Colombia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ancient remedies put to the test against pneumonia in the elderly
- New antibiotic lefamulin takes on Drug-Resistant pneumonia
- Could your Child's cough help diagnose asthma or pneumonia?
- Herbal formula NRICM102 tested as pneumonia Add-On treatment
- Pneumonia drug trial aims to protect arteries from hidden damage
- Could less be more? new trial tests lower antibiotic dose for pneumonia